CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...